Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Recruiting

Registered drugNo placebo

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Urinary tract infection

Not yet recruiting

Registered drug

MV140 for Women with Recurrent Uncomplicated Urinary Tract Infections

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Ascorbic Acid

Contact Research Centre

Arteriosclerosis

Not recruiting

Investigational

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational

Portugal

Participants:18–64 years · 65+ years

Contact Research Centre

Ischaemic stroke+2

Not recruiting

Investigational

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Asundexian

Contact Research Centre

Systemic lupus erythematosus

Not recruiting

Investigational

Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Deucravacitinib

Contact Research Centre

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Not recruiting

Registered drugNo placebo

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

HIV infection

Not recruiting

Registered drugNo placebo

Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Bictegravir

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Non-small cell lung cancer+1

Not recruiting

Registered drugNo placebo

Study Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Asthma

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

Registered drug

Portugal

Participants:0–17 years · 18–64 years · 65+ years
Substances:Budesonide

Contact Research Centre

Malignant peritoneal neoplasm+2

Not recruiting

Registered drugNo placebo

Study of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Paclitaxel

Contact Research Centre

Arteriovenous graft thrombosis

Not recruiting

Investigational

Study on MK-2060 for Preventing Blood Clots in Dialysis Patients with End-Stage Kidney Disease

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Mk-2060

Contact Research Centre

Find therapies in clinical trials near you – page 2

30 trials match your criteria

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Urinary tract infection

MV140 for Women with Recurrent Uncomplicated Urinary Tract Infections

Arteriosclerosis

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Ischaemic stroke+2

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Systemic lupus erythematosus

Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

HIV infection

Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients

Hormone receptor positive HER2 negative breast cancer

Study on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer

Non-small cell lung cancer+1

Study Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Asthma

Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

Malignant peritoneal neoplasm+2

Study of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Arteriovenous graft thrombosis

Study on MK-2060 for Preventing Blood Clots in Dialysis Patients with End-Stage Kidney Disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.